Bronchoscopic lung volume reduction is a treatment offered to patients with severe heterogenous emphysema
Perch, M.; Titlestad, I.L.; Rychwicha-Kielek, B.A.; Bendstrup, E.; Iversen, M.; Siemsen, M.; Jørgensen, O.D.; Haahr, P.E.
Ugeskrift for Laeger 176(29): V01140005
2014
ISSN/ISBN: 1603-6824 PMID: 25292200 Document Number: 675780
Introduction of bronchoscopic lung volume reduction as a treatment for severe emphysema has been defined as an area of development by The Danish Health and Medicines Authority. We here present the rationale for treatment, in- and exclusion criteria, and ultimately the organization for assessment, treatment and follow-up in Denmark. The treatment aim is to lower dyspnoea. There is a national protocol for patient selection according to in- and exclusion criteria. Different commercial devices are available, but endobronchial valves have been the devices mostly applied. A national database has been established to evaluate cost-effectiveness.